pg
robust top-line result support view pg organ
sale growth trajectori sustain improv enabl
organiz chang combin inflect
gross margin drive above-p ep growth
larg ep pg stock rose vs post strong
result strong organ sale growth vs market
expect inflect gross margin expans bp consensu
combin lower expect sg drove oper
profit beat top-line strength driven above-consensu sale everi
divis match pg organ sale growth pg best
organ sale growth year despit challeng comparison result
impress key detail underscor
continu bullish forward outlook pg pg averag organ
sale growth best result decad well
well two-yr average quarterli org sale growth
acceler remain in-lin sequenti six straight quarter
strong ep result despit moder price result help allevi
concern potenti deceler growth price dissip
gross margin expans strong bp y-o-i confirm upsid
potenti forecast base detail gm build see continu
runway out-performance balanc year cost save ramp
pg categori growth slightli acceler improv us categori volum
growth good sign top pg market share gain pg substanti
reinvest behind busi invest market
innov bp yoy sale bp increas
drive forward pg market share balance-of-year guidanc look
conserv beat net result give us greater convict
call pg organ top-line growth sustain rebound
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
inflect key driver ow thesi see pg stock still
compel valuat close peer despit clearli superior lt
topline/ep growth mind
call detail organ sale growth broad-bas pg categori
grow organ sale geograph region grow higher
weight pg average market share gain bp y-o-i in-lin bp trail
twelve-month averag pg continu see strong result top two market
us china china posit broad-bas strong growth
beauti even ex olay sk-ii us overal vs
track channel growth delta track untrack
almost entir due faster growth non-track channel untrack channel
growth particularli strong organ sale growth e-commerc
strong club channel trend call pg emphas way
made improv across valu chain lean innov
invest disrupt retail execut technology-en brand
build enabl pg new organiz structur took effect
juli price like dissip pg cycl increas
promot pick lower commod sound like price
environ remain ration far call pg note
japan vat-rel time impact benefit compani sale result
bp becom headwind pg also comp earn gain
loss land sale oral brand divestitur
rais ep estim strong result rais ep
y-o-i high end pg growth guidanc
impli rang pt increas higher ep
greater confid higher pg growth peer
detail pg fiscal core ep consensu
mse high qualiti larg top-line upsid robust organ sale
growth bp gm beat drive oper profit beat vs
consensu organ sale growth ahead consensu
street expect two-year averag growth top-line
growth balanc price volum mix price
sequenti vs
ep organ sale growth guidanc rais pg rais
organ sale growth guidanc vs prior all-in sale growth
also vs prior reflect modest neg impact fx
unchang like slightli wors un-round larg off-set posit
impact acquisit divestitur unchang pg rais core
ep growth guidanc y-o-i base impli
midpoint prior consensu
mse view ep rais clearli posit pg
assum greater reinvest behind busi rais guidanc
peer ep estim move fx etc posit pg
posit ep revis balanc fiscal year pg rais adjust free
cash flow product vs prior pg still expect pay
billion dividend unchang repurchas billion common
exhibit pg average organ sale growth acceler end
exhibit led improv categori growth share gain
strong segment result pg segment organ sale result better
expect across board upsid vs consensu segment beauti
strong volum price mix vs consensu
mse skin person organ sale mid-teen driven
growth super-premium sk-ii brand olay skin increas price
hair organ sale increas msd health volum
price mix vs consensu mse
health dd due innov higher retail inventori build versu
base period cough cold season favor mix due higher
growth north america higher averag sell price oral
hsd premium innov increas posit mix fabric
volum price flat mix vs consensu mse
hsd growth fabric babi feminin
 famili organ sale volum price mix vs
consensu mse babi increas lsd due
devaluation-rel price increas posit mix growth premium
product partial off-set competit activ categori contract
certain market feminin famili organ sale increas hsd
due posit product mix innov higher price groom
volum price mix flat vs consensu mse
strong across board m-hsd result sizeabl area
weak north america groom groom segment
call pg note geograph region grew higher
organ sale focu market enterpris market hsd
us track channel
deriv base case scenario
upsid bp us upsid pg marketing/innov focu drive
market share improv cut forecast better
expect price realiz drive margin upsid turn ep growth
valuat expand ep
strong sale growth margin expans forecast organ sale growth
go forward hpc peer led improv us result build
market share momentum better price realiz continu cost save
support bp om expansion/yr drive hsd ep growth appli
multipl ep slight premium pg average given
us led topline/margin downsid us bear case scenario play
bp pricing/volum downsid along bp margin downsid greater
reinvest outsid us bp top-line downsid bp
margin downsid drive mute lsd ep growth valuat contract
believ strategi tweak put place recent
year bear fruit acceler pg
top-line growth back rang
us improv breadth perform
confid market share momentum
sustain combin
improv price outlook greater agil
organiz chang implement
support top-line growth hpc peer
year fy gross margin declin see fy
gm inflect led improv price
realiz commod tailwind
combin sizabl cost save program
worth annual profit see scope
bp annual margin expans
turn hsd ep growth deliveri
next sever year
valuat look compel rel
basi pg trade ep
close peer rel valuat look
compel consid call pg
fundament posit inflect year
under-perform vs expens hpc
risk achiev price
market share vacil currenc
exhibit bear bull top-line trend stock driver
valu
sale
sale
sale bp chang
sale
sale bp chang
prepaid expens current asset
note loan payabl
current portion long-term debt
accru liabil
reserv esop debt retir
depreci amort
chang a/l
a/p accru liabil
oper asset liabil
provid oper
flow invest activ
proce asset sale
payment acquisit
use invest activ
flow financ activit
chang short-term debt
chang long-term debt
purchas treasuri share
use financ activ
provid discontinu oper
exchang rate effect
net increas decreas equiv
equiv beg
equiv end
